MannKind
MannKind Corporation focuses on the development and commercialisation of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercialising its US FDA-approved Afrezza® (insulin human) Inhalation Powder.
Headquarters
MannKind Corporation
30930 Russell Ranch Road, Suite 300
Westlake Village
CA 91362
United States
MannKind Corporation focuses on the development and commercialisation of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercialising Afrezza® (insulin human) Inhalation Powder, the company’s first US FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the US, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, CA, US, and has a state-of-the art manufacturing facility in Danbury, CT, US. The Company also employs field sales and medical representatives across the US.
